國立虎尾科技大學 |

Health Technology Assessment in Japan = Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Health Technology Assessment in Japan/ by Isao Kamae.
其他題名:	Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /
作者:	Kamae, Isao.
面頁冊數:	XVI, 269 p. 118 illus., 94 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Health economics. -
電子資源:	https://doi.org/10.1007/978-981-13-5793-0
ISBN:	9789811357930

Health Technology Assessment in Japan = Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /
Kamae, Isao.

Health Technology Assessment in JapanPolicy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /[electronic resource] :by Isao Kamae. - 1st ed. 2019. - XVI, 269 p. 118 illus., 94 illus. in color.online resource.

1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7．Advanced Research Topics.

Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.

ISBN: 9789811357930

Standard No.: 10.1007/978-981-13-5793-0doiSubjects--Topical Terms:

810102
Health economics.

LC Class. No.: RA410-410.9

Dewey Class. No.: 338.473621

Health Technology Assessment in Japan = Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /
LDR:02540nam a22003855i 4500 001 1009730
003 DE-He213
005 20200706123619.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811357930 $9 978-981-13-5793-0
024 7 $a 10.1007/978-981-13-5793-0 $2 doi
035 $a 978-981-13-5793-0
050 4 $a RA410-410.9
072 7 $a KCQ $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KCVJ $2 thema
082 0 4 $a 338.473621 $2 23
100 1 $a Kamae, Isao. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1303723
245 1 0 $a Health Technology Assessment in Japan $h [electronic resource] : $b Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond / $c by Isao Kamae.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2019.
300 $a XVI, 269 p. 118 illus., 94 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7．Advanced Research Topics.
520 $a Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
650 0 $a Health economics. $2 bicssc $3 810102
650 0 $a Pharmacy management. $3 1236292
650 1 4 $a Health Economics. $3 786205
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 1063577
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811357923
776 0 8 $i Printed edition: $z 9789811357947
856 4 0 $u https://doi.org/10.1007/978-981-13-5793-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)